Sort
23,748 grants matching “melanoma”
Clinical production of viral vectors for cancer gene therapy
$1,026,237Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma
$1,025,001Margaret Kenny Offermann · Oncospherix, Inc. · R44 · FY2024 · CA
Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma
$1,024,999Margaret Kenny Offermann · Oncospherix, Inc. · R44 · FY2023 · CA
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma
$1,024,973Yen Tun Wang · Curebiotech, Inc. · R44 · FY2019 · CA
Phase 1 cross over biodistribution study of [203Pb]VMT01 for single photon emission computed tomography (SPECT) and [68Ga]VMT02 for positron emission tomography (PET) imaging of stage 4 melanoma
$1,023,920Frances L Johnson · Viewpoint Molecular Targeting, Inc. · R44 · FY2020 · CA
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke
$1,023,777Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$1,023,526Tomas G Neilan · Massachusetts General Hospital · R01 · FY2025 · HL
Genomic Sunlight Dosimeters for Melanoma Prevention
$1,022,551Douglas E Brash · Yale University · P50 · FY2016 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,022,419Stuart H. Yuspa · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Genetic Epidemiology of Melanoma
$1,022,023David E E Elder · University Of Pennsylvania · R01 · FY2007 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$1,021,968Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Genomic Sunlight Dosimeters for Melanoma Prevention
$1,021,612Douglas E Brash · Yale University · P50 · FY2014 · CA
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
$1,020,835Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2018 · CA
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
$1,020,143Jelena Levi · Cellsight Technologies, Inc. · R44 · FY2017 · CA
Molecular Mechanisms Of Cell Adhesion And Invasion
$1,019,179Steven Akiyama · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Pre-cancer atlas of skin cancer
$1,019,013Alan Hunter Shain · University Of California, San Francisco · U01 · FY2024 · CA
Oncogenic Kinase complexes
$1,018,257Ping Zhang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT
$1,017,690University Of Arizona · P01 · FY2003 · CA
Biology and genetics of metastatic disease
$1,017,000Sohail F. Tavazoie · Rockefeller University · R35 · FY2025 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$1,017,000Mark Reid Philips · New York University School Of Medicine · R35 · FY2021 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$1,016,977Mark Reid Philips · New York University School Of Medicine · R35 · FY2025 · CA
Prospective study of cutaneous viral infections and non-melanoma skin cancer
$1,016,129Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Protein Misfolding and Aggregation
$1,015,912Jennifer Lee · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$1,015,591Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2021 · CA
Family Studies
$1,014,835Margaret Tucker · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA